Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
Xiaoling Xu, Ding Wang, Wei Chen, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 12, pp. 4511-4525
Open Access | Times Cited: 15

Showing 15 citing articles:

Prognostic Value of Peripheral Blood Lymphocyte Subsets in Children and Adolescents with High‐Grade Mature B‐Cell Non‐Hodgkin Lymphoma: A Real‐World Outcomes Study
Chenggong Zeng, Zhiqing Wei, Junting Huang, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Prognostic Value of Circulating Lymphocyte Subsets in Cervical Cancer Following Postoperative Radiotherapy
Shanshan Wang, Mengli Zhao, Zhongrong Gao, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1029-1038
Open Access
Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab
Yuichi Honma, Michihiko Shibata, Masatoshi Ikemi, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1274-1274
Open Access
Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy
Xin Yang, Qiao Li, Tianyang Zeng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer
Jie Xie, Xiao Xu, Zhenjia Dong, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 963-975
Open Access | Times Cited: 6
The inter-link of ageing, cancer and immunity: findings from real-world retrospective study
Xiaomin Fu, Peng Qin, Fanghui Li, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Short-term prognostic role of peripheral lymphocyte subsets in patients with gastric cancer
Chun Gao, Yi Xin Tong, Li Zhu, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109641-109641
Open Access | Times Cited: 8
Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
Xiuqiong Chen, Zhaona Li, Jing Zhou, et al.
PeerJ (2022) Vol. 10, pp. e14566-e14566
Open Access | Times Cited: 5
The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma
Qu Xie, Can Hu, Cong Luo
Journal of Cancer (2023) Vol. 14, Iss. 15, pp. 2946-2955
Open Access | Times Cited: 2
Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study
Yuyang Wang, Jingjuan Zhu, Na Zhou, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 10, pp. 5669-5679
Open Access | Times Cited: 2
Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer
Yan Yang, Jie Du, Yunfei Huang, et al.
Oncology Letters (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 2
Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy
Patricia Mondelo‐Macía, Luís León, David Bernardo, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 5, pp. 957-961
Open Access | Times Cited: 1
Clinical Efficacy of Anti-programmed Death Ligand 1 Immunotherapy Combined with Chemoradiotherapy in the Treatment of Limited-stage Small Cell Lung Cancer and Its Effect on Serum Tumor Markers and T Lymphocyte Subsets
Zhaoxue Lu, Shuai Li, Ying Li, et al.
Research Square (Research Square) (2023)
Closed Access
Peer Review #2 of "Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors (v0.1)"

(2022)
Open Access
Peer Review #3 of "Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors (v0.1)"

(2022)
Open Access
Page 1

Scroll to top